Edwards Lifesciences CEO sells 2,920.5511 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp CEO Bernard J. Zovighian reported several Common Stock transactions dated July 27, 2026. He made bona fide gifts totaling 639.2998 shares, moving 319.6499 shares out of direct ownership and 319.6499 shares into a trust, while an affiliated trust sold 2,920.5511 shares at $83.9342 per share. Following these changes, he directly held 98,845 shares, with an additional 3,733.5603 shares held indirectly through a 401(k).
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 319.6499 | $0.00 | $0.00 |
| Gift | Common Stock | 319.6499 | $0.00 | $0.00 |
| Sale | Common Stock | 2,920.5511 | $83.9342 | $245K |
| Holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
Bona fide gift financial
beneficial ownership financial
indirect ownership financial
401(k) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock transactions did Edwards Lifesciences (EW) CEO Bernard J. Zovighian report?
What gifts of Edwards Lifesciences (EW) stock did the CEO report?
What are Bernard J. Zovighian’s holdings in Edwards Lifesciences (EW) after these transactions?
Were the Edwards Lifesciences (EW) CEO’s reported transactions under a Rule 10b5-1 trading plan?
How is indirect ownership reported for the Edwards Lifesciences (EW) CEO in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.